1991
DOI: 10.1128/jvi.65.9.4735-4740.1991
|View full text |Cite
|
Sign up to set email alerts
|

RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases

Abstract: The recently reported nucleotide sequence of coxsackievirus A9 (CAV-9) showed that unlike other enteroviruses, CAV-9 has an insertion of about 17 amino acids at the C-terminal end of VP1 (K. H. Chang, P.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
56
0

Year Published

1997
1997
2010
2010

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 138 publications
(60 citation statements)
references
References 25 publications
3
56
0
Order By: Relevance
“…This function was clearly impaired by infection with the isolate DM. Paananen et al coxsackievirus A9 [Roivainen et al, 1991] and other picornaviruses: foot-and-mouth disease virus [Berinstein et al, 1995;Neff et al, 1998] and human parechovirus 1 [Roivainen et al, 1991;Stanway et al, 1994;Joki-Korpela et al, 2001]. RGD-independent receptor binding to vitronectin has been reported for hantavirus [Gavrilovskaya et al, 1998].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This function was clearly impaired by infection with the isolate DM. Paananen et al coxsackievirus A9 [Roivainen et al, 1991] and other picornaviruses: foot-and-mouth disease virus [Berinstein et al, 1995;Neff et al, 1998] and human parechovirus 1 [Roivainen et al, 1991;Stanway et al, 1994;Joki-Korpela et al, 2001]. RGD-independent receptor binding to vitronectin has been reported for hantavirus [Gavrilovskaya et al, 1998].…”
Section: Discussionmentioning
confidence: 99%
“…The assay was carried out in confluent GMK cells in six well plates as described earlier [Roivainen et al, 1991]. Briefly, the cells were exposed either to RRRGDLpeptide (50 ml/well) at a 1 mM concentration or to polyclonal rabbit antiserum (50 ml/well) to the vitronectin receptor, a v b 3 , at a dilution of 1:50.…”
Section: Plaque Protection Assaymentioning
confidence: 99%
“…Integrin v 3 (Roivainen et al, 1991;Roivainen et al, 1994;Berinstein et al, 1995;Triantafilou et al, 1999); GRP78 (Triantafilou et al, 2002); MHC class I via 2 -microglobulin (Triantafilou et al, 1999) Coxsackievirus B1-6 CAR (Bergelson et al, 1997;Shafren et al, 1997c;Tomko et al, 1997;Martino et al, 2000;He et al, 2001); murine CAR (Tomko et al, 1997;Bergelson et al, 1998) Coxsackievirus B1, B3, B5 DAF Shafren et al, 1995;Martino et al, 1998); integrin v 6 (Agrez et al,…”
Section: Coxsackievirus A9mentioning
confidence: 99%
“…Titres for infectious virus in the heart and plasma samples were detected using the plaque-forming assay as previously described [18]. Myocardial tissue sections of each animal were stained with haematoxylin-eosin for histopathological analysis.…”
Section: Experimental Myocarditis Virus Titration and Histopathologymentioning
confidence: 99%